Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Oncology Institute Inc shares valued at $42,500 were purchased by Hively Brad on Nov 26 ’24. At $0.17 per share, Hively Brad acquired 250,000 shares. The insider’s holdings grew to 616,753 shares worth approximately $0.59 million following the completion of this transaction.
Also, Hively Brad purchased 50,000 shares, netting a total of over 7,500 in proceeds. Following the buying of shares at $0.15 each, the insider now holds 666,753 shares.
Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in mid September. As of August 15, 2022, Jefferies has initiated its “Buy” rating for TOI.
Analyzing TOI Stock Performance
During the last five days, there has been a drop of approximately -0.42%. Over the course of the year, Oncology Institute Inc shares have jumped approximately 209.39%. Shares of the company reached a 52-week high of $1.1700 on 02/26/25 and a 52-week low of $0.2519 on 01/10/25. A 50-day SMA is recorded $0.5933, while a 200-day SMA reached $0.4432. Nevertheless, trading volume fell to 3.73 million shares from 0.18 million shares the previous day.
Support And Resistance Levels for Oncology Institute Inc (TOI)
According to the 24-hour chart, there is a support level at 0.8208, which, if violated, would cause prices to drop to 0.6856. In the upper region, resistance lies at 1.1306. The next price resistance is at 1.3052. RSI (Relative Strength Index) is 60.95 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0484, which suggests the price will decrease in the coming days. Percent R is at 51.16%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
